Company Overview of Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutic products for unmet medical needs and disorders relating to the central nervous system in Georgia. Its products include TIK-101 for treatment of anxiety disorders; and TIK-101, a formulation of an HDAC inhibitor, for possible treatment of spinal muscular atropy. The company was incorporated in 2005 and is based in Atlanta, Georgia.
75 Fifth Street, NW
Atlanta, GA 30308
Founded in 2005
Key Executives for Tikvah Therapeutics, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Tikvah Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.